LKFT

Lakefront Biotherapeutics Stock Analysis

AI Rating

Neutral
  • Quality6/10
  • Growth↓ 2/10
  • Value↑ 6/10
Lakefront Biotherapeutics sales and earnings growth
LKFT Growth
Fair
  • Revenue Y/Y↑ 239.93%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↑ 9.87%
Lakefront Biotherapeutics gross and profit margin trends
LKFT Profitability
Great
  • Gross margin ↑ 97.90%
  • EPS margin↑ 49.70%
  • ROIC 5Y↑ 0.00%
Lakefront Biotherapeutics net debt vs free cash flow
LKFT Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Lakefront Biotherapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks